Research and New Product Development Centered on Core Technologies
First written in FY2016. 25 of 37 entries say "Restated". Latest entry: FY2026.
6 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,060 million, and the purposes, key issues, results and R&D expenses for each business are as follows.」
The company recorded R&D expenses of ¥1,060 million and advanced the development and commercialization of recycled PVC protective boards, biodegradable films, heat-shielding films, noncombustible thermal insulation materials and semiconductor-related components, among others. - 2026-05-12AdvancedEarnings presentation
「Rebuilding the R&D structure and establishing a collaborative framework to advance priority development themes」
The company specifically outlined the rebuilding of its R&D structure and a collaborative framework for advancing priority themes. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥521 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥521 million for the six-month cumulative consolidated period. - FY2025AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,132 million, and the purposes, key issues, results and R&D expenses for each business are as follows.」
The company recorded R&D expenses of ¥1,132 million and advanced the development of biomass-based materials, thermal insulation materials, antistatic films, generative AI and image analysis AI, and recycling technologies, among others. - FY2025-H1RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥558 million.」
The company continued its R&D activities and discloses R&D expenses of ¥558 million for the six-month cumulative consolidated period. - FY2024AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,226 million, and the purposes, key issues, results and R&D expenses for each business are as follows.」
The company recorded R&D expenses of ¥1,226 million and advanced the development and launch of biodegradable films, biomass-based materials, conductive upholstery materials, specialty polyurethane foam, AI image analysis and recycling technologies, among others. - FY2024-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥918 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥918 million for the nine-month cumulative period. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥601 million.」
The company continued its R&D activities and discloses R&D expenses of ¥601 million for the six-month cumulative period. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative consolidated period were ¥296 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥296 million for the three-month cumulative period. - FY2023AdvancedAnnual report
「As environmentally conscious products, the company advanced the development of flexible polyurethane foam manufactured using recycled carbon dioxide and the broad deployment of biodegradable films for agricultural, forestry and livestock applications, food packaging and other uses. As a product for creating comfortable living spaces, it developed a conductive upholstery material for vehicles with static-eliminating performance.」
In R&D centered on its core technologies, the company advanced the development and deployment of recycled-carbon-dioxide-based foam, biodegradable films and conductive upholstery materials. R&D expenses were ¥1,260 million. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥942 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥942 million for the nine-month cumulative period. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥615 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥615 million for the six-month cumulative consolidated period. - FY2023-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative consolidated period were ¥310 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥310 million for the three-month cumulative period. - FY2022AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,359 million.」
The company recorded R&D expenses of ¥1,359 million and reports the development and launch of antiviral shoes, films for preventing droplet transmission, biomass-based materials, ACROFOAM and insulated boxes, as well as the expansion of their applications. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥682 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥682 million for the six-month cumulative period. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative consolidated period were ¥332 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥332 million for the three-month cumulative period. - FY2021AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,415 million, and the purposes, key issues, results and R&D expenses for each business are as follows.」
The company recorded R&D expenses of ¥1,415 million and reports the development and launch of ACROFOAM, antiviral films, medical films and conductive wafer carriers, among other products. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥1,036 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥1,036 million for the nine-month cumulative consolidated period. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥677 million.」
The company continued R&D activities centered on its core technologies and discloses R&D expenses of ¥677 million for the six-month cumulative period. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative consolidated period were ¥345 million.」
The company continued its R&D activities and reports R&D expenses of ¥345 million for the three-month cumulative period. - FY2020AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,460 million, and the purposes, key issues, results and R&D expenses for each business are as follows.」
The company recorded R&D expenses of ¥1,460 million and reports the development and launch of high-performance thermal insulation materials, biodegradable films, temperature-regulating polyurethane foam and new conductive-grade spacers, among other products. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥1,083 million.」
The company continued its R&D activities and reports total R&D expenses of ¥1,083 million for the nine-month cumulative consolidated period. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥713 million.」
The company continued R&D centered on its core technologies and reports R&D expenses of ¥713 million for the six-month cumulative consolidated period. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative consolidated period were ¥361 million.」
The company continued its R&D activities and reports R&D expenses of ¥361 million for the three-month cumulative consolidated period. - FY2019AdvancedAnnual report
「In industrial materials, the company began selling the NA-300LA 12-inch HWS wafer carrier, which has a structure that absorbs shock during silicon wafer transport and supports automated handling.」
The company reports the commercialization of R&D results, including the launch of sales of 12-inch wafer carriers, as part of R&D centered on its core technologies. R&D expenses were ¥1,442 million. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥1,076 million.」
The company continued its R&D activities and reports total R&D expenses of ¥1,076 million for the nine-month cumulative period. - FY2019-Q2RestatedAnnual report
「The total R&D expenses for the cumulative period through the second quarter were ¥697 million.」
The company continued its R&D activities and reports total R&D expenses of ¥697 million for the six-month cumulative period. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative consolidated period were ¥351 million.」
The company continued its R&D activities and reports total R&D expenses of ¥351 million for the three-month cumulative consolidated period. - FY2018AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥1,503 million, and the purposes, key issues, results and R&D expenses for each business are as follows.」
The company recorded R&D expenses of ¥1,503 million and reports the development and launch of temperature-regulating polyurethane foam, high-performance thermal insulation materials and electroless plating technology, among other products and technologies. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥1,121 million.」
The company continued its R&D activities and reports total R&D expenses of ¥1,121 million for the nine-month cumulative period. - FY2018-Q2RestatedAnnual report
「In addition, since its founding, the company has continued to enhance its plastics processing capabilities, developing distinctive technologies including compounding, film-making, foaming, thermal insulation and conductivity technologies, integrating and combining them to provide customers with products for everyday use and original products.」
The company continues to develop technologies centered on plastics processing and provide products through their integration and combination. R&D expenses for the six-month cumulative consolidated period were ¥735 million. - FY2018-Q1RestatedAnnual report
「In addition, since its founding, the company has continued to enhance its plastics processing capabilities, developing distinctive technologies including compounding, film-making, foaming, thermal insulation and conductivity technologies, integrating and combining them to provide customers with products for everyday use and original products.」
The company continues R&D centered on plastics processing technologies and the integration and combination of technologies. R&D expenses for the three-month cumulative consolidated period were ¥355 million. - FY2017AdvancedAnnual report
「With energy conservation, the environment and health as its keywords, the company has conducted R&D centered on its core plastics processing technologies, including molding, film-making and foaming, to improve and advance its existing technologies and continue proposing original products. R&D expenses for the consolidated fiscal year were ¥1,513 million.」
The company continued R&D centered on its core technologies, recorded R&D expenses of ¥1,513 million, and developed thermal insulation materials, biodegradable films and temperature-regulating polyurethane foam, among other products. - FY2017-Q3RestatedAnnual report
「Since its founding, the company has continued to enhance its plastics processing capabilities, developing distinctive technologies including compounding, film-making, foaming, thermal insulation and conductivity technologies, and has integrated and combined these technologies to provide new products. Total R&D expenses for the nine-month cumulative consolidated period were ¥1,106 million.」
The company continues to provide products through the development and integration of proprietary technologies centered on plastics processing, and reports total R&D expenses of ¥1,106 million. - FY2017-Q2RestatedAnnual report
「Since our founding, we have continuously enhanced our plastic processing capabilities, developed distinctive technologies including compounding, film-making, foaming, thermal insulation and imparting electrical conductivity, and combined and integrated these technologies to provide new products. Total R&D expenses for the first 6 months of the current consolidated cumulative period were ¥738 million.」
The company continues to provide products through the development and integration of proprietary technologies centered on plastics processing, and reports R&D expenses of ¥738 million for the cumulative period. - FY2017-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥371 million.」
R&D activities continued, with total R&D expenses for the quarter reported at ¥371 million. - FY2016First statedAnnual report
「We have conducted research and development centred on our core plastic processing technologies, including moulding, film-making and foaming, to improve and advance our existing technologies under the themes of energy conservation, the environment and health, and to continue proposing original products.」
Research and development based on plastic processing technology was conducted with a focus on energy conservation, the environment and health, and R&D expenses for the current fiscal year were ¥1,484 million.